top of page
FM Home Hero (1).png

Meet the Leadership

Experience & Expertise

Meet the leadership team addressing site-level trial challenges and driving clinical trial innovation across Europe

Meet the Executive Leadership Team

Our Executive Leadership Team combines visionary leadership with decades of industry expertise to drive strategic growth, ensuring we deliver unparalleled value for our clients, patients, and shareholders. 

Meet the Senior Management Team

Our Senior Leadership Team excels in translating strategy into action, leveraging their deep operational knowledge to create exceptional outcomes that benefit our patients, clients, and stakeholders alike. 

Dr Radek Janiak

Chief Executive Officer

Radoslaw studied medicine at the University of Warsaw graduating in 1997. After working as a hospital doctor for 4 years he moved into clinical research initially as a site director for a Polish CRO.  Working for Synexus from 2005 until 2019 he was responsible for the rapid growth of the business across Central and Eastern Europe. He was appointed COO in 2015.

Radek_Janiak_FutureMeds.webp

Iwona Tongbhoyai

Chief Client Solutions Officer

With over 15 years of site and clinical trials management background and more than 7 years of business consultancy experience, Iwona has a unique blend of expertise and a strong focus on strategic planning. Prior to FutureMeds, she was responsible for improving the efficiency of the global start-up, clinical trial and site operational readiness across over 160 sites and 17 countries at a global site network. At FutureMeds, she plays a key role in growing site network and building lasting relationships with Sponsors and CROs. She specializes in DCTs and strives to help Sponsors and CROs develop and deploy strategies and solutions that positively impact research timelines and drive medical progress. 

Group 33915 (3).png

Marcin Gondek

Chief Financial Officer

Marcin is a graduate in Economics from the University of Wroclaw.  He spent 10 years working in senior finance roles for a number of multinational companies.  He joined Synexus in 2012, initially as finance director for Central and Eastern Europe and has extensive knowledge of site operations, feasibility and contracting.  Marcin was appointed as CFO of Synexus in 2017 and lead the integration of the European and US businesses.

Marcin_Gondek_FutureMeds.webp

Melanie Manners

Global HR Director

Melanie Manners, a strategic and entrepreneurial global HR executive, thrives in dynamic environments and is driven by leaving a positive legacy. With 25+ years of experience across SMEs and global markets, she was formerly VP People at Eagle Genomics. An honors graduate, FCIPD Fellow, leadership coach, and Six Sigma Green Belt holder, she’s committed to building capable teams and excellence in people management. 

Melanie_manners.jpeg

Paul Chambers

Chairman

Paul graduated from the University of Sheffield before training as a Chartered Accountant with KPMG.  He spent five years in Practice before moving into industry.  Formerly CFO of Synexus from 2010-2017, leading the business through a period of substantial growth culminating in two successful private equity exits. Paul is currently a non-executive director of The North West Fund.

Paul_Chmabers_FutureMeds.webp

Cameron Glen

VP of Global BD

Cameron has a unique blend of industry experience and knowledge. He spent 23 years of his career building & forging alliances and pursuing new business for notable public and private sector players such as Menarini Pharmaceuticals, AstraZeneca, University of Dundee/NHS Tayside, Synexus, and industry-leading CROs such as Covance Inc. (Labcorp R&D) and ICON plc.

Cameron_Glen_FutureMeds_edited.jpg

Wojciech Szczepanik

EVP of Site Operations

Wojciech, with a PhD in biomedicinal chemistry, began his clinical trials career as a monitor at AstraZeneca in 2005, focusing on cardiology, pulmonology, and oncology. He later joined Synexus, leading its growth for 11 years. As VP of International Site Network at Pratia, he focused on mergers and acquisitions, driving the expansion of its international site network. As an Executive VP of Operations at FutureMeds, he plays a key role in the sustainable expansion of the site network. 

Wojtek2_FutureMeds.jpeg

Grzegorz KrówczyÅ„ski

VP of IT

Grzegorz KrówczyÅ„ski VP of IT LinkedIn With over 17 years of professional experience and deep domain knowledge of Business Intelligence, Data Management and Clinical Trial Management Systems, Grzegorz plays a key role in building FutureMeds' IT arm and ensuring that the company is fully prepared and ready for driving innovations in the Clinical Trials market.

Grzegorz_FutureMeds.webp

Małgorzata Herrera

Director of Feasibility & Proposals

Maggie is a seasoned professional with 14 years of clinical research experience. Known for her passion, strategic decision-making, and team-oriented approach, she previously held key roles at Synexus, including leading their global feasibility department. Before joining FutureMeds she worked as Senior Director of Feasibility at AES. 

Małgorzata_Herrera_FutureMeds.jpeg

Nachiket Chandak

Senior Director of BD

Nach has held various sales positions, driving revenue growth for industry leaders. Starting at Datamonitor Healthcare in 2007, he gained insights into clinical development. He then excelled at PPD, ICON Plc, and Parexel, forging partnerships and advancing phase II-III research. 

nach_futuremeds.jpeg

John Allen

Managing Director, United Kingdom

With over 15 years clinical research experience and a background as a qualified accountant, John brings a unique blend of expertise to our team. His commitment to high patient recruitment have been pivotal in establishing multiple sites for FutureMeds UK.  John Allen leadership and extensive knowledge are instrumental in making a positive impact in UK clinical research.

john_allen_FutureMeds.webp

Rocio Diaz Sanchez

Managing Director, Spain

With over 12 years of experience in Research Management in different academic institutions and private hospitals, Rocio Diaz, in her role of Managing Director of FutureMeds Spain aims to bring the patients’ the best treatment. Through her continued commitment to excellence, Rocio strives to contribute further to the betterment of society.

Rocio_Diaz_FutureMeds.webp

Dr. Piotr Rozpondek MD PhD

Managing Director, Poland

As Managing Director of FutureMeds Poland, Piotr aims to further improve access for patients to clinical trials using virtual visits and home nursing, advance decentralized clinical trials processes, start hospital-based new sites, and introduce oncology studies to FutureMeds’ therapeutic areas.

Piotr_FutureMeds.webp

Ivan Vyshnyvetskyy MD Ph.D.

Managing Director, Ukraine

Ivan, an associate professor at Bogomolets National Medical University in Kyiv, Ukraine, has over 20 years of experience in medical practice and clinical research. He is an Investigator with 50+ clinical trials experience, including 30+ trials as a PI and is the President of the Ukrainian Association for Clinical Research, which, under his governance, became an influential Ukrainian professional society in the field.

ivan_futuremeds.webp

Borislav Borissov MD MBA, DSc

Managing Director, Bulgaria

Prof. Dr. Borislav Borissov, MD, MBA, DSc, with over 31 years of medical and over 11 years of clinical trials management experience, will be responsible for leading FutureMeds’ Bulgarian operations and extending FutureMeds' network of medical research clinics into Bulgaria.

Borislav_Futuremeds.webp

Ninon Armburst

Head of Sites, Germany

A former qualified nurse with operating theatre experience, has over 10 years in clinical research. As Site Director at FutureMeds Berlin, she led her team in delivering complex trials to the highest standards.  

ninon_amburst_Futuremeds_edited.jpg

Nicole Bohrmann

Director of Decentralized Operations

Nicole, with experience as Site Manager and Territory Director at Synexus, and Senior Project Manager at Marken, brings exceptional leadership to FutureMeds. Her career highlights include winning the VIP Award Germany, completing a high-potential leadership program, and supporting global Home Health Care initiatives. Starting as a study nurse, Nicole’s firsthand insights into patient care have been invaluable throughout her clinical trial career. 

image 11 (3).png
bottom of page